CLASS II Device recall · Reported 21 Jun 2017 · FDA Enforcement Report

ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are recalled

Arrow International is recalling ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to permit venous access to, distributed nationwide in the US. The recall was initiated on 9 May 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMaterial number: CDC-24301-1A, CDC-24306-1A Device Listing D025398
Quantity recalled27,485 units distributed in U.S., 4,371 units distributed internationally

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2337-2017
FDA event ID
77232
Recalling firm
Arrow International, Reading, PA
Classification
Class II
Status
Terminated
Recall initiated
9 May 2017
FDA classified
12 Jun 2017
Reported
21 Jun 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 May 2017Recall initiated by company
12 Jun 2017Classified by FDA+34 days
21 Jun 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access

Product as listed by the FDA

ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to permit venous access to the central circulation

Where it was distributed

Worldwide Distribution - US (nationwide) and Canada

Nationwide

Questions about this recall

Is ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to permit venous access to recalled?

Yes. Arrow International recalled ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to permit venous access to on 9 May 2017. The recall is Class II and its status is Terminated. Recall number Z-2337-2017.

Why was it recalled?

The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access

Which lots are affected?

Material number: CDC-24301-1A, CDC-24306-1A Device Listing D025398

Where was it sold?

Worldwide Distribution - US (nationwide) and Canada

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Arrow International

All 525

Other Other Medical Devices recalls

All 13,778